
July 2022 to June 2023
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| MOLNUPIRAVIR | $663,936,115 | 596,498 |
| ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR | $513,178,072 | 24,023 |
| AFLIBERCEPT | $490,856,261 | 456,479 |
| PEMBROLIZUMAB | $460,100,246 | 54,210 |
| NIVOLUMAB | $424,490,187 | 57,842 |
| USTEKINUMAB | $358,351,536 | 49,180 |
| NIRMATRELVIR (&) RITONAVIR | $342,269,060 | 296,787 |
| APIXABAN | $314,435,185 | 3,832,322 |
| ADALIMUMAB | $285,048,311 | 333,243 |
| DENOSUMAB | $279,039,646 | 1,108,531 |
| DUPILUMAB | $260,243,826 | 151,977 |
| OCRELIZUMAB | $212,854,222 | 12,459 |
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ROSUVASTATIN | $110,363,403 | 16,743,927 |
| ATORVASTATIN | $90,739,212 | 12,339,003 |
| PANTOPRAZOLE | $76,835,602 | 10,390,610 |
| ESOMEPRAZOLE | $76,014,257 | 8,423,568 |
| PERINDOPRIL | $47,023,089 | 7,211,157 |
| ESCITALOPRAM | $25,700,669 | 6,170,172 |
| METFORMIN | $45,955,137 | 5,978,742 |
| SERTRALINE | $26,364,217 | 5,758,922 |
| CEFALEXIN | $24,830,662 | 5,188,470 |
| AMLODIPINE | $33,271,301 | 4,942,428 |
| AMOXICILLIN | $17,624,287 | 4,844,595 |
| TELMISARTAN | $28,196,332 | 4,598,903 |
| Contributor | Contribution Dollars |
|---|---|
| Australian Government | $17,044,737,720 |
| Patients | $3,434,187,492 |